Suppr超能文献

利用工程化的巨型核酸酶生成 Rag1 基因敲除免疫缺陷型大鼠和小鼠。

Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases.

机构信息

Institut National de Santé et de Recherche Médicale (INSERM) Unité Mixte de Recherche1064, Center for Research in Transplantation and Immunology and Platform Transgenic Rats Nantes Infrastructures en Biologie Sante et Agronomie, Centre National de Recherche Scientifique, Nantes, France.

出版信息

FASEB J. 2013 Feb;27(2):703-11. doi: 10.1096/fj.12-219907. Epub 2012 Nov 12.

Abstract

Despite the recent availability of gene-specific nucleases, such as zinc-finger nucleases (ZFNs) and transcription activator-like nucleases (TALENs), there is still a need for new tools to modify the genome of different species in an efficient, rapid, and less costly manner. One aim of this study was to apply, for the first time, engineered meganucleases to mutate an endogenous gene in animal zygotes. The second aim was to target the mouse and rat recombination activating gene 1 (Rag1) to describe, for the first time, Rag1 knockout immunodeficient rats. We microinjected a plasmid encoding a meganuclease for Rag1 into the pronucleus of mouse and rat zygotes. Mutant animals were detected by PCR sequencing of the targeted sequence. A homozygous RAG1-deficient rat line was generated and immunophenotyped. Meganucleases were efficient, because 3.4 and 0.6% of mouse and rat microinjected zygotes, respectively, generated mutated animals. RAG1-deficient rats showed significantly decreased proportions and numbers of immature and mature T and B lymphocytes and normal NK cells vs. littermate wild-type controls. In summary, we describe the use of engineered meganucleases to inactivate an endogenous gene with efficiencies comparable to those of ZFNs and TALENs. Moreover, we generated an immunodeficient rat line useful for studies in which there is a need for biological parameters to be analyzed in the absence of immune responses.

摘要

尽管最近出现了基因特异性核酸酶,如锌指核酸酶(ZFNs)和转录激活因子样核酸酶(TALENs),但仍需要新的工具以高效、快速且低成本的方式来修饰不同物种的基因组。本研究的一个目的是首次应用工程化的巨核酸酶来突变动物受精卵中的内源性基因。第二个目的是靶向小鼠和大鼠重组激活基因 1(Rag1),首次描述 Rag1 基因敲除免疫缺陷大鼠。我们将编码巨核酸酶的质粒显微注射到小鼠和大鼠受精卵的原核中。通过对靶向序列的 PCR 测序来检测突变动物。生成了纯合的 Rag1 基因缺失大鼠品系并进行了免疫表型分析。巨核酸酶非常有效,因为分别有 3.4%和 0.6%的小鼠和大鼠显微注射受精卵产生了突变动物。与同窝野生型对照相比,Rag1 基因缺失大鼠的未成熟和成熟 T 和 B 淋巴细胞以及正常 NK 细胞的比例和数量明显减少。总之,我们描述了使用工程化巨核酸酶来灭活内源性基因,其效率可与 ZFNs 和 TALENs 相媲美。此外,我们生成了一种免疫缺陷大鼠品系,可用于需要在没有免疫反应的情况下分析生物学参数的研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验